On June 17th, 2020 John Hopkins University announced the launch of a breakthrough new clinical research trial on the use of a Keto diet for Intubated Critical Care COVID-19 (KICC-COVID19).
In recent years, research around the interplay between diet, disease, and health outcomes has been rapidly expanding. We’ve seen new research on the use of a keto diet for numerous different conditions. The following are just a few to highlight the vast variety between different diseases and disorders the ketogenic diet may be useful for:
- Allergies & asthma
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Cancer (general), thyroid cancer, glioblastomas
- Cardiovascular Health
- Fatty Liver Disease
- Fragile X Syndrome
- GLUT1 Deficiency Syndrome
- Influenza Virus (the Flu)
- Multiple Sclerosis
- Parkinson’s Disease
- Polycystic Kidney Disease
- Polycystic Ovarian Syndrome (PCOS)
- Substance Abuse Disorder / Drug Addiction
- Traumatic Brain Injury
This list is only the tip of the iceberg, so you can get a pretty good idea as to why researchers may want to look into the therapeutic benefits of a ketogenic for illnesses like COVID-19.
So, What Is This Study Looking At?
This keto research study aims to look at the beneficial use of a ketogenic diet for COVID-19 patients that are currently intubated and in critical care.
Why Do They Think Keto Can Help COVID Patients?
There are several reasons the ketogenic diet may be beneficial for patients in critical care. The researchers in this study believe that patients currently in need of ventilation will benefit from a 4:1 ketogenic diet through the following means:
- Improvement in gas exchange
- Reduction in inflammation
- Reduction in duration of need for mechanical ventilation
What Will The Researchers Be Looking For?
The primary outcome that the researchers will be looking at is the change in the partial pressure of carbon dioxide (PaCO2). This value will help determine whether or not the ketogenic diet has helped improve gas exchange (which can also be caused by a reduction in inflammation).
More Details About This Keto Research Trial
Study details: Single-center, open-label, clinical trial (interventional)
Methods: This keto research study will involve feeding 15 intubated COVID-19 patients a 4:1 ketogenic diet within 48 hours of intubation.
Time-Frame: Estimated to begin on September 1, 2020, estimated study completion date on December 31, 2021
Read More About this keto research trial at: https://clinicaltrials.gov/ct2/show/NCT04358835
Chelsea Malone works as a researcher in the field of health and performance supplementation. She contributes science-based articles and information to Ketogenic.com. She received her Bachelor of Science in Biomedical Sciences from the University of Central Florida and her Master of Science in Medical Sciences from the University of South Florida. Her specialties are in biochemistry, immunology, and pathophysiology. In her free time, she enjoys cooking, traveling, hiking, and reading.